Search

Author/Creator Lawitz, Eric

41. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019)

Authors:
Younossi, Zobair M; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M; Goodman, Zachary; Bedossa, Pierre; Geier, Andreas; Beckebaum, Susanne; Newsome, Philip N; Sheridan, David; Sheikh, Muhammad Y; Trotter, James; Knapple, Whitfield; Lawitz, Eric; Abdelmalek, Manal F; Kowdley, Kris V;...
Journal:
Lancet
Issue:
Volume 394:Issue 10215(2019)
Page Start:
2184
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

42. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019)

Authors:
Younossi, Zobair M; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M; Goodman, Zachary; Bedossa, Pierre; Geier, Andreas; Beckebaum, Susanne; Newsome, Philip N; Sheridan, David; Sheikh, Muhammad Y; Trotter, James; Knapple, Whitfield; Lawitz, Eric; Abdelmalek, Manal F; Kowdley, Kris V;...
Journal:
Lancet
Issue:
Volume 394:Issue 10215(2019)
Page Start:
2184
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

43. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019)

Authors:
Younossi, Zobair M; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M; Goodman, Zachary; Bedossa, Pierre; Geier, Andreas; Beckebaum, Susanne; Newsome, Philip N; Sheridan, David; Sheikh, Muhammad Y; Trotter, James; Knapple, Whitfield; Lawitz, Eric; Abdelmalek, Manal F; Kowdley, Kris V;...
Journal:
Lancet
Issue:
Volume 394:Issue 10215(2019)
Page Start:
2184
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

46. Positive Results From REGENERATE: A Phase 3 International, Randomized, Placebo‐Controlled Study Evaluating Obeticholic Acid Treatment for NASH: 938. (October 2019)

Authors:
Younossi, Zobair; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M.; Goodman, Zachary; Bedossa, Pierre; Geier, Andreas; Beckebaum, Susanne; Newsome, Philip; Sheridan, David; Trotter, James; Knapple, Whitfield; Lawitz, Eric; Kowdley, Kris; Montano‐Loza, Aldo; Boursier, Jerome; Mathuri...
Journal:
American journal of gastroenterology
Issue:
Volume 114 (2019)ACG Abstracts 1:Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

47. Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II). Issue 7 (4th August 2015)

Authors:
Zeuzem, S.; Flisiak, R.; Vierling, J. M.; Mazur, W.; Mazzella, G.; Thongsawat, S.; Abdurakhmanov, D.; Van Kính, N.; Calistru, P.; Heo, J.; Stanciu, C.; Gould, M.; Makara, M.; Hsu, S.‐J.; Buggisch, P.; Samuel, D.; Mutimer, D.; Nault, B.; Merz, M.; Bao, W.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 42:Issue 7(2015)
Page Start:
829
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

48. S0988 Health Outcomes in Patients With Hepatic Encephalopathy Managed Through Telemedicine and a Specialized Pharmacy Team. (October 2020)

Authors:
Wells, Jennifer; Rodas, Fabian; Loo, Nicole; Landaverde, Carmen; Guerrero, Richard; Ramirez, Ruben; Kim, Jae D.; Hanysak, Bryan; Mitchell, Robert; Van Frank, Timothy; Tsai, Eugenia; Christensen, Kimberley; Hinojosa, Kim; Olvera, Nina; Pham, Tram; Lawitz, Eric; Pedicone, Lisa D.; Poordad, Fred
Journal:
American journal of gastroenterology
Issue:
Volume 115:Supplement(2020)ACG Annual Meeting Abstracts 1
Page Start:
S503
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

49. S1371 High SVR Rates, Regardless of Race or Socioeconomic Class, in Patients Treated With HCV DAAs in Community Practice Using a Specialized Pharmacy Team. (October 2022)

Authors:
Kuwelker, Saatchi; Basra, Tamneet; Nguyen, Harry; Kim, Jae; Mitchell, Robert; Ramirez, Ruben; Guerrero, Richard; Hanysak, Bryan; Landaverde, Carmen; Rodas, Fabian; Tsai, Eugenia; Lawitz, Eric; Christensen, Kimberley; Vaughn, Clarissa; Hinojosa, Kim; Olvera, Nina; Caraballo-Gonzalez, Edna; Pham, E...
Journal:
American journal of gastroenterology
Issue:
Volume 117:Number 10(2022)supplement 10ES
Page Start:
e985
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

50. Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trials. (November 2017)

Authors:
Lawitz, Eric; Buti, Maria; Vierling, John M; Almasio, Piero L; Bruno, Savino; Ruane, Peter J; Hassanein, Tarek I; Muellhaupt, Beat; Pearlman, Brian; Jancoriene, Ligita; Gao, Wei; Huang, Hsueh-Cheng; Shepherd, Aimee; Tannenbaum, Brynne; Fernsler, Doreen; Li, Jerry J; Grandhi, Anjana; Liu, Hong; Su...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 2:Number 11(2017)
Page Start:
814
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗